GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3030)

  • GC91427 structure
    GC91427Glutaminase C Inhibitor 11
    Purity: >95.00%

    글루타미네이스 C 억제제 11은 글루타미네이스 C (GAC)의 억제제입니다.

  • GC91595 structure
    GC91595PDIC-NC
    CAS: 2633013-75-7
    Purity: >95.00%

    PDIC-NC is an activator of stimulator of interferon genes (STING) and an anticancer agent.

  • GC91688 structure
    GC91688PDIC-NN
    CAS: 932740-48-2
    Purity: >95.00%

    PDIC-NN is an intermediate in the synthesis of PDIC-NS , an activator of stimulator of interferon genes (STING) with anticancer activity.

  • GC91782 structure
    GC91782DPP-9 Inhibitor 42
    Purity: >95.00%

    DPP-9 inhibitor 42 is an inhibitor of dipeptidyl peptidase 9 (DDP-9; IC50 = 0.0034 µM).

  • GC91820 structure
    GC91820PDIC-NS
    Purity: >95.00%

    PDIC-NS is an activator of stimulator of interferon genes (STING).

  • GC91967 structure
    GC91967LMTK3 Inhibitor C28
    CAS: 2764850-23-7
    Purity: >98.00%

    LMTK3 Inhibitor C28 는 다효소 억제제의 일종이다.

  • GC91977 structure
    GC91977TrkB Agonist Prodrug R13
    CAS: 1609067-49-3
    Purity: >95.00%

    TrkB Agonist Prodrug R13 (R13) 는 원근구단백질 관련 효소 B (TrkB) 활성제 7,8 - 디옥시플라본의 전약 형태이다.

  • GC92023 structure
    GC92023PTX80
    CAS: 2376297-69-5
    Purity: >95.00%

    PTX80은 p62의 옹색제(대인수용체의 IC50=31.18nM)다.

  • GC92037 structure
    GC92037JQKD82 (hydrochloride)
    CAS: 2863676-87-1
    Purity: >98.00%

    JQKD82 (hydrochloride)는 lysine-specific demethylase 5A (KDM5A) 로도 알려진 Jumonji AT-rich interactive domain 1A (JARID1A)의 억제제인 KDM5-C49의 프로 약물 형태입니다.

  • GC92066 structure
    GC92066RMC-6236
    CAS: 2765081-21-6
    Purity: >99.00%

    RMC-6236은 가역적 GTP-결합 RAS (ON) 다중 선택성 억제제이다.

  • GC92074 structure
    GC920741,2,3-Trioleoyl Glycerol-d5
    CAS: 60892-83-3
    Purity: >99.00%

    1,2,3-Trioleoyl Glycerol-d5는 GC-또는 LC-MS에 의한 1,2,3-trioleoyl glycerol의 정량을위한 내부 표준으로 사용하기위한 것입니다.

  • GC92099 structure
    GC92099MSG606 (trifluoroacetate salt)
    Purity: >95.00%

    MSG606 (trifluoroacetate salt)은 멜라토닌 수용체 1의 펩타이드 옹색제(MC1R; 인간 수용체에 대한 IC50=17nM)와 감마-멜라토닌 세포 자극 호르몬(감마-MSH)의 파생물이다.

  • GF04703 structure
    GF04703Phosphocreatine di-tris salt
    CAS: 108321-17-1
    Purity: >97.00%

    Phosphocreatine di-tris salt은 척추동물과 일부 무척추동물의 근육에서 고에너지 인산염 저장고 역할을 하고 ADP를 ATP로 전환을 위해 인산염을 제공하는 인산화된 크레아틴 분자이다.

  • GF11023 structure
    GF11023Hecubine
    CAS: 62874-52-6
    Purity: >98.00%

    Hecubine is a natural aspidosperma-type alkaloid found in E. officinalis , with anti-neuroinflammation properties.

  • GF15486 structure
    GF15486Cathepsin B from bovine spleen
    CAS: 9047-22-7

    Cathepsin B from bovine spleen B(Cathepsin B)는 시스테인 효소 파파인 유사 가족의 일원이다. Cathepsin B는 335개의 아미노산으로 구성된 프로프로테인으로 합성되고 계산된 분자량은 약 36.7kDa이다. Cathepsin B는 엔도솜/리소좀 부위에 위치하고 이곳에서 Cathepsin B는 엔도펩티다제와 엑소펩티다제로 기능한다. Cathepsin B는 주로 세포 내외의 단백질의 회전에 참여하고 세포 내의 안정적인 대사 활동을 유지한다.

  • GF17531 structure
    GF175318-Epixanthatin
    CAS: 30890-35-8
    Purity: >98.00%

    8-Epixanthatin은 해바라기 하배축의 광향성 곡률을 조절하는 광유도 성장 억제제이다.

  • GN10005 structure
    GN10005Schisandrin C
    CAS: 61301-33-5
    Purity: >99.50%
  • GN10017 structure
    GN10017Wogonin
    CAS: 632-85-9
    Purity: >98.00%

    Wogonin is a potent and competitive inhibitor of CYP1A2 with a K i value of 0.24μM.

  • GN10019 structure
    GN10019Ginsenoside Rg6
    CAS: 147419-93-0
    Purity: >99.50%
  • GN10030 structure
    GN10030Fisetin
    CAS: 528-48-3
    Purity: >98.00%

    Fisetin은 많은 과일과 채소에 존재하는 천연 플라보놀이고 다양한 생물학적 활성을 가지고 있다.

  • GN10035 structure
    GN100359-Methoxycamptothecin
    CAS: 19685-10-0
    Purity: >99.00%
  • GN10037 structure
    GN10037Bisdemethoxycurcumin
    CAS: 33171-05-0
    Purity: >98.00%
  • GN10038 structure
    GN10038Ginsenoside Rh3
    CAS: 105558-26-7
    Purity: >99.50%
  • GN10040 structure
    GN10040Dehydrocorydaline
    CAS: 30045-16-0
    Purity: >98.00%

    Dehydrocorydaline은 코리달리스 리좀의 4가 암모늄 알칼로이드 중 하나이다.